Boston Scientific Corporation (BSX) vs Cardinal Health, Inc. (CAH)
A side-by-side comparison of Boston Scientific Corporation and Cardinal Health, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.
BSX
Boston Scientific Corporation
$46.73HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT
CAH
Cardinal Health, Inc.
$230.03HealthcareAt close: Jul 31, 2026, 4:00 PM ET
Total return — BSX vs CAH
growth of $100 · dividends reinvested · last 30yBSX +318.9%CAH +1662.8%CAH compounded faster
BSX CAH
BSX vs CAH: by the numbers
- •BSX is the larger company ($69.46B vs $53.87B market cap).
- •BSX trades at the lower trailing earnings multiple (19.00 vs 35.17 P/E), one valuation lens rather than an overall verdict.
- •BSX converts more revenue to profit (17.48% vs 0.62% net margin).
- •BSX grew revenue faster over the past five years (13.40% vs 9.86% CAGR).
- •CAH pays a dividend (0.89% yield), while BSX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BSX | CAH |
|---|---|---|
| P/E ratio | 19.00 | 35.17 |
| Forward P/E | 14.11 | 21.35 |
| P/S ratio | 3.30 | 0.22 |
| P/B ratio | 2.70 | N/A |
| PEG ratio | 0.88 | 0.30 |
| EV / EBITDA | 14.14 | 18.71 |
| FCF yield | 4.93% | 8.09% |
Profitability
| Metric | BSX | CAH |
|---|---|---|
| Gross margin | 71.16% | 3.68% |
| Operating margin | 21.60% | 0.92% |
| Net margin | 17.48% | 0.62% |
| ROE | 14.19% | -56.13% |
| ROIC | 8.78% | 11.37% |
Dividends
| Metric | BSX | CAH |
|---|---|---|
| Dividend yield | N/A | 0.89% |
| Payout ratio | N/A | 31.60% |
Growth (annualized)
| Metric | BSX | CAH |
|---|---|---|
| Revenue CAGR (5Y) | 13.40% | 9.86% |
| EPS CAGR (5Y) | N/A | 6.11% |
| FCF CAGR (5Y) | 19.89% | 22.47% |
| Total return CAGR (5Y) | 0.49% | 33.99% |
Frequently asked
- Which has the lower trailing P/E, BSX or CAH?
- BSX has the lower trailing P/E: BSX trades at 19.00 and CAH at 35.17. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BSX or CAH?
- Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus CAH at 9.86%.
- Does BSX or CAH pay a bigger dividend?
- CAH pays a dividend (0.89% yield), while BSX has no payments in the available dividend history.
- Is BSX or CAH more profitable?
- BSX runs the higher net margin — BSX at 17.48% versus CAH at 0.62%.
- How have BSX and CAH total returns compared?
- Over the past 10 years, BSX delivered 6.76% and CAH delivered 13.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Boston Scientific P/E ratioCardinal Health P/E ratioBoston Scientific dividend yieldCardinal Health dividend yieldBoston Scientific ROECardinal Health ROEBoston Scientific operating marginCardinal Health operating marginBoston Scientific revenue growthCardinal Health revenue growthBoston Scientific free cash flowCardinal Health free cash flow
Boston Scientific & Cardinal Health appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.